Promising new leprosy vaccine moves into human trials

(Infectious Disease Research Institute) Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans for a promising leprosy vaccine candidate -- the first vaccine developed specifically for leprosy.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news